Business Wire

THALES

25.1.2021 10:02:13 CET | Business Wire | Press release

Share
NATO Selects Thales to Supply Its First Defence Cloud for the Armed Forces

NATO has selected Thales to provide the first certified defence cloud solution that can be deployed in the theatre of operations in less than 24 hours. Thales was selected after a worldwide competitive tendering process on the basis of its defence systems integration know-how. With this contract, the Group enters a new market sector and demonstrating its capacity to integrate the best civil and commercial technologies available and to adapt them to the needs of the armed forces.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210125005006/en/

As military operations become increasingly data-driven, access to critical data and applications is a crucial requirement for the armed forces. The defence cloud developed by Thales enables the forces to analyse and share data in real time from the command centre to the theatre of operations, pursue their digital transformation in complete security, and accelerate the decision cycle to gain and maintain an operational advantage.

Until now, it could take several months and dozens of specialised engineers working at sites close to the combat zone to deploy the assets required. With Nexium Defence Cloud and its Service Design Studio and orchestration system, a small team of experts can deploy IT services and applications to locations thousands of kilometres away in just a few hours. This solution is based on a holistic approach encompassing applications management, IT, networks and security, with an overall system architecture designed to accommodate various different levels of confidentiality.

Nexium Defence Cloud incorporates the best civil and commercial technologies available to provide a complete, modular, sovereign solution that enables forces to operate fully autonomously in the theatre of operations. It offers a wide array of possible configurations, from very high-capacity and easily scalable infrastructure for command headquarters to all-in-one containerised systems that transform a forward base into a new cloud node in just a few hours.

This easy interconnection within ad hoc organisations and command structures increases mission effectiveness with an unparalleled level of security.

Nexium Defence Cloud is the most compact, highly integrated and modular solution available today. It includes all the components of military command posts (cabinets, servers, data storage media, supervision system, etc.) and meets performance requirements in terms of size, weight and power (SWaP) to simplify deployment and minimise the logistics footprint.

Through this contract, Thales once again demonstrates its system certification and standardisation know-how. Its defence cloud solution was designed to comply with the requirements of NATO's Federated Mission Networking (FMN) standard, which establishes the framework for cooperation between command-and-control networks for coalition forces. Nexium Defence Cloud has all the strengths needed to become the benchmark solution for the high-value-added deployable command posts that will be required for the coalition operations of tomorrow.

"Thales is proud to be contributing to the digital transformation of the armed forces by providing this first deployable, certified, tactical defence cloud solution. We are grateful to NATO for renewing their trust in our expertise in secure, interoperable information and communication systems." Marc Darmon , Executive Vice-President, Secure Communications and Information Systems, Thales.

About Thales

Thales (Euronext Paris: HO) is a global high technology leader investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum technology – to build a future we can all trust, which is vital to the development of our societies. The company provides solutions, services and products that help its customers – businesses, organisations and states – in the defence, aeronautics, space, transportation and digital identity and security markets to fulfil their critical missions, by placing humans at the heart of the decision-making process.

With 83,000 employees in 68 countries, Thales generated sales of €19 billion in 2019 (on a basis including Gemalto over 12 months).

PLEASE VISIT
Thales Group
Market

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 12:00:00 CET | Press release

Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe

SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 11:40:00 CET | Press release

Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amo

NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 11:00:00 CET | Press release

NIQ’s new solution brings unprecedented clarity into package types, materials, and true consumption across markets, closing critical industry gaps NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding

European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 08:47:00 CET | Press release

European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili

Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 01:00:00 CET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye